Pharmaceutical formulations comprising high-purity cangrelor and their methods of preparation and use
MA41326B1Active Publication Date: 2026-08-31CHIESI FARMACEUTICI SPA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA41326
- Authority / Receiving Office
- MA · MA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-07-10
- Filing Date
- 2015-07-10
- Publication Date
- 2026-08-31
- Estimated Expiration
- 2035-07-10
Abstract
The present invention relates to a high-purity cangrelor, pharmaceutical formulations comprising cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in inhibiting platelet activation and aggregation.
Need to check novelty before this filing date? Find Prior Art